Wang et al. demonstrated that approximately 13% of triple-negative breast cancer cases carry NOTCH1 mutations, which are centered in the PEST domain, and ultimately lead to the activation of the Notch signaling pathway [52]. Here, NOTCH1 is linked to triple-negative breast carcinoma.